KTOV I think we will never have another stock/opp.like kitov. $25m Cap for a one of a kind combo( Kitov’s drug passed Phase III with stunning results),on the market that handles both things together - in pain as a result of osteoarthritis and high blood pressure. Therefore, the KIT-302 is the only drug with indication for the treatment of pain while reducing the risk of heart attack and stroke may even brought a dying patient. we are one step before NDA.
"People are going to use this... At the price range similar to branded Celebrex, it would enter the formulatory without a problem." That's $7 per pill a day. on conservative estimations by experts about 12m people in the US alone will use kitov's drug dialy. that's $84m a day (or 3-4 times kitov's current cap).
Even at $0.25 a pill a day would be a revenue of $795m/yr those numbers based on US market only. add also also 7-10 yrs in EU and the rest of the World. Even w/$100m/year, present value based on US patent years is more than $1b in the US alone.
we might see a $300m-$1b BO here even before the drug hit the market.imo
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
